Abathengi bethu
*Abathengi abadwelisiweyo abachaswa xa bebhengezwa
China Beijing Tongrentang Group Co., Ltd.
I-Tong Ren Tang yasekwa ngo-1669. Ikhethekileyo kumayeza emveli aseTshayina kubandakanywa amayeza, impilo kunye nokuphila kakuhle, ukhathalelo lwezonyango eziphezulu, ukuthengisa, njl. Inezityalo ezingaphezu kwe-36 zamachiza e-China ezivelisa ngaphezu kwe-2,600 amayeza kunye nezongezo zokutya, kunye neevenkile ezingaphezu kwe-2,400 zokuthengisa kunye namaziko onyango. Ikwamise kumazwe angama-28 kunye nemimandla, kubandakanya i-USA, iCanada, i-UK, iNetherlands, iSweden, iSwitzerland, njl. Ngo-2018, uTong Ren Tang ubhalise ingeniso ye-2.7 yezigidigidi ze-USD, kunye ne-asethi engaphezulu kwe-4.1 yezigidigidi ze-USD.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
I-China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. yinkampani enkulu karhulumente edweliswe kuluhlu lwamayeza, ebandakanyeka kakhulu kuphando nophuhliso, imveliso, intengiso kunye neenkonzo zempilo ezinxulumene neemveliso zamayeza. Ishishini eliphambili le-CR Sanjiu likwintsimi yeemveliso zonyango lwe-CHC kunye namachiza achazwe ngugqirha, kunye noluhlu olubanzi lweemveliso kunye nokuqhubeka nokutyebisa imigca yemveliso kunye neentlobo. Ishishini lezempilo labathengi le-CHC libandakanya phantse iindidi ezili-10, ezibandakanya ukubanda kunye nomkhuhlane, ulusu, isisu, ukhohlokhohlo, amathambo, izifo zabantwana, izongezo zokutya, njl. ishishini layo elimiselweyo liquka i-anti-tumor, i-cardiovascular and cerebral vascular, i-gastrointestinal, i-orthopedics, i-pediatrics kunye nezinye iindawo zonyango, kwaye inandipha udumo oluphezulu kwicala lezonyango. Ngo-2022, ingeniso ye-CR Sanjiu yayiyi-2.58 yeebhiliyoni zeedola.
Ujongilanga Pharmaceutical Group Co., Ltd.
Iqela likajongilanga Pharmaceutical Group liphethe inani leenkampani zesebe ezifana namashishini okuvelisa amayeza, iinkampani zamachiza, amaziko ophando ngamachiza, izityalo zokulima imifuno, njl. njl kunye nezongezo zokutya. Phakathi kwabo, i-Pediatric Lung-Heat Cough & Asthma Oral Liquid / Particles iye yaqatshelwa yi-China Non-prescription Medicines Association (CNMA) njenge "No. 1 kwicandelo lokubanda kwabantwana kunye nokukhohlela kwamayeza aseShayina" iminyaka emininzi ngokulandelelana. Ngo-2022, ingeniso ye-Sunflower Pharmaceutical Group yafikelela kwi-720 yezigidi ze-USD, kunye ne-500 yezigidi ezivela kwiyeza lelungelo elilodwa lomenzi waseTshayina.
Iqela leLivzon Pharmaceutical Inc.
I-Livzon Pharmaceutical Group Inc., eyasekwa ngo-1985, yinkampani ebanzi yoxubo-mayeza edibanisa iR&D yamayeza, ukuvelisa kunye nokuthengisa kunye nabasebenzi abangaphezu kwama-8,000. Iqela ngoku livelisa kwaye lithengise amachiza ekhemikhali, amayeza elungelo elilodwa lomenzi waseTshayina, amayeza ebhayoloji, kunye ne-in vitro diagnostic reagents kwimimandla yokugaya, intliziyo kunye ne-cerebrovascular, i-endocrinology yokuzala, kunye nengqondo/neurological. Ngo-2022, ingeniso yeqela ifikelele kwi-1.8 yezigidigidi zeedola, kunye ne-200 yezigidi zeedola zotyalo-mali kwi-R&D.
I-Dihon Pharmaceutical Group Co., Ltd.
I-Dihon Pharmaceutical Group Co., Ltd., eyasungulwa ngo-1993, ngoku iyinkampani encedisayo ye-Bayer. Iphakathi kweenkampani eziphezulu ze-OTC ezili-10 eTshayina. Eyona mveliso iphambili yiCompound Ketoconazole Ointment kwiingxaki zolusu. Ingeniso yayo yonyaka imalunga ne-200 yezigidi ze-USD.
IGolden Throat Holdings Group Company Limited
I-Golden Throat Holdings Group Company Limited, eyasekwa ngo-1956, iye yaba yenye yabenzi bamayeza angama-50 aphezulu waseTshayina emva kweminyaka yophuhliso. Eli qela ligxile kakhulu kwiinkalo zamayeza e-patent yaseTshayina kunye nezongezo zokutya, kwaye ngoku linamayeza angaphezu kwama-60 elungelo elilodwa lomenzi wechina. Eyona mveliso ibalulekileyo iGolden Throat Lozenge ithunyelwe kumazwe angaphezu kwama-50 nakwimimandla eseMntla Melika, eYurophu nakumazantsi-mpuma eAsia. Kwi-2022, ingeniso yeqela yayiyi-140 yezigidi ze-USD.
Yangtzi River Pharmaceutical Group
I-Yangztzi River Pharmaceutical Group, eyasekwa ngo-1971, liqela lamaShayina loxubo-mayeza elidweliswe nguMphathiswa wezeNzululwazi neTekhnoloji njengelinye lamaShishini aQalayo aQalayo eTshayina kwaye inabasebenzi abangaphezu kwe-16,000. Iimveliso zibandakanya amachiza ekhemikhali, amayeza elungelo elilodwa lomenzi wechiza, iimveliso zokhathalelo lwempilo olubanzi, njl.njl. Ngomzamo weqela, imigangatho emi-5 yamazwe ngamazwe yezixhobo zonyango zaseTshayina ingene kwi-European Pharmacopoeia. Ukongeza eTshayina, iimveliso zayo ziye zathengiswa kumazwe angaphezu kwama-50 kunye nemimandla. Ngo-2022, ingeniso yoMlambo waseYangtzi yayingaphezu kwe-11 yeebhiliyoni zeedola.
Beihai Gofar Chuanshan Biological Co., Ltd.
I-Beihai Gofar Chuanshan Biological Co., Ltd. isekwe kwi-1993. Yeyona nkampani kuphela edwelisiweyo ekhethekileyo emanzini olwandle ipearl oyster (i-Hepu Southern Pearl / Hepu Akoya pearl), i-algae, i-crustaceans kunye nezinye izixhobo ezikhethekileyo zebhayoloji uphuhliso oluhlanganisiweyo, ukusetyenzwa kwe-China. Ishishini layo eliphambili kukuvelisa amayeza, ukuhanjiswa kwamayeza, iinkonzo zobuchwepheshe bezonyango kunye nokuxilongwa kweemolekyuli kunye namashishini e-forensic. Ngo-2022, ingeniso yeGofar yayizizigidi ezingama-66 zeedola.
IHumanwell Healthcare (iQela) Co., Ltd.
I-Humanwell Healthcare yasekwa ngo-1993. Yenze ubunkokeli okanye isikhundla esiphambili kumacandelo amachiza e-neurological, amachiza ehomoni ye-steroid, amachiza e-Uyghur ethnic, njl. Kwiminyaka yakutshanje, ngokuthe ngcembe iye yandisa ishishini layo le-generics yaseMelika. Lenze iR&D yehlabathi, ubhaliso, imveliso kunye nentengiso yekhonkco lexabiso lilonke lamayeza, ukuthunyelwa kumazwe angama-70 nakwimimandla yehlabathi jikelele. Ngo-2022, ingeniso ye-Humanwell Healthcare yayiyi-3.2 yeebhiliyoni zeedola.
Iqela le-SCIMYTH Pharmaceutical Group
Iqela le-SCIMYTH Pharmaceutical Group yinkampani enkulu ebanzi kunye neyeza njengeyona nto iphambili, ukudibanisa ukulinywa kwemifuno, uphando lweziyobisi kunye nophuhliso, ukuthengiswa kweziyobisi kunye neenkonzo zonyango ezibandakanya abantwana, i-gynecology, intliziyo, ukuphefumla, i-oncology, iziyobisi zonyango kunye nezinye iinkalo. Ngo-2022, ingeniso yayo yafikelela kwi-74 yezigidi zeedola. Kuqikelelwa ukuba kunengeniso ye-700 yeebhiliyoni zeedola ngo-2025.
Shandong Hanfang Pharmaceutical Co., Ltd.
I-Shangdong Hanfang Pharmaceutical Co., Ltd., eyasekwa ngo-2004, lishishini elitsha langoku lamayeza emveli aseTshayina elidibanisa uphando nophuhliso, imveliso kunye neentengiso. liqela elixubeneyo lamayeza elithatha ishishini lamayeza emveli aseTshayina njengelona candelo liphambili, kwaye lidibanisa ubuchwephesha bebhayoloji, izixhobo zonyango, kunye namayeza emveli aseTshayina okuthambisa.
ILuoxin Pharmaceutical Group Stock Co., Ltd.
I-Luoxin Pharmaceutical Group Stock Co., Ltd., eyasungulwa kwi-1998, yintlangano yokunakekelwa kwezempilo ebandakanyeka kuphando lwamachiza kunye nophuhliso, ukuvelisa, ukuthengisa kunye nenkonzo yezempilo. Ingeniso yeLuoxin ngo-2022 yayiyi-512 yezigidi zeedola.
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
I-Guangdong Zhongsheng Pharmaceutical Co., Ltd. yasekwa kwi-1979. Ngokusekwe kwiinkalo zonyango lwe-ophthalmology, i-cardiovascular, izifo zokuphefumla kunye nezokugaya ukutya, inkampani igxile kuphando lwamachiza olutsha kunye nophuhliso kwiindawo ezizodwa ezifana nomkhuhlane, i-non-alcoholic steatohepatitis (NASH), izifo, i-ophthalmetabolism kunye nokuveliswa kwayo. Elona shishini. Elona shishini liphambili lale nkampani libandakanya iR&D, ukuveliswa kunye nokuthengiswa kwamayeza emveli aseTshayina anelungelo elilodwa lomenzi wechiza, amayeza ekhemikhali, imathiriyeli zonyango yamaTshayina kunye nezilayi zamaShayina zamakhambi, i-API yemichiza, kunye notyalo-mali kumashishini anxulumene ne-ophthalmology. Ngo-2022, ingeniso yenkampani yayizizigidi ezingama-382 zeedola.
I-Hunan Brilliance & Abundance Scientific Chinese Herbal Medicine Co., Ltd.
I-Hunan Brilliance & Abundance Scientific Chinese Herbal Medicine Co., Ltd., yasekwa ngo-2002, lishishini lanamhlanje loxubo lwezamayeza olunamayeza aseTshayina amaqhekeza e-ultra-micro decoction njengeyona mveliso iphambili kunye namalungiselelo amayeza kunye nezicatshulwa zamayeza aseTshayina njengamaphiko amabini.
I-Apeloa Pharmaceutical Co., Ltd.
I-Apeloa Pharmaceutical Co., Ltd., eyasekwa ngo-1989, iye yaseka iR&D yonyango elungileyo kunye nobuchule bokuvelisa, isenza amacandelo amathathu aphambili oshishino lwe-API, CDMO, kunye neFom yeDosage egqityiweyo (FDF). I-Apeloa ibe yinkampani yasekhaya ekhokelayo kwii-API ezikhethekileyo.
Njengomboneleli-nkonzo ophambili weshishini leCDMO kwikhonkco leshishini leziyobisi lehlabathi, i-Apeloa iye yakha ubudlelwane bentsebenziswano bexesha elide kunye neenkampani eziphezulu zasekhaya kunye nezangaphandle ezinkulu ze-pharma kunye ne-biotech, kwaye udale iimpawu zasekhaya ezaziwayo ezifana ne "Baishixin" kunye ne "Tianliwei". Iyeza lokuqala le-Apeloa elikumgangatho ophezulu elilawulwayo lithe laziswa kurhwebo lwase-US. Ngoku inabasebenzi abangaphezu kwe-1,000 kwi-R&D. Ngo-2022, uApeloa ufikelele kwingeniso ye-1.5 yezigidigidi zeedola.
I-Hunan Heng Chang Pharmaceutical Group Co., Ltd.
I-Hunan Heng Chang Pharmaceutical Group Co., Ltd., eyasekwa ngo-2015, lishishini lokusasaza amayeza e-B2B eligxile ekukhonzeni iikhemesti ezincinci kunye nobukhulu obuphakathi, iikhemesti kunye namaziko okhathalelo lwempilo olusisiseko aquka imimandla eyahlukeneyo efana namayeza e-patent yaseTshayina, amayeza asentshona, amayeza emveli aseTshayina, amayeza abantwana kunye nezixhobo zokhathalelo lwempilo. Ukuza kuthi ga ngoku, iQela lisebenze ngaphezu kweendidi ezingama-2,000, kubandakanywa neemveliso ezingaphezu kwe-1,600 phantsi kohlobo lwayo, kwaye inabathengi abangaphezu kwe-100,000 ababhalisiweyo ababhalisiweyo, phakathi kwabo abaphantse babe ngama-50,000 bangabathengi abasebenzayo. Kwi-2022, ingeniso ye-Heng Chang yayiyi-700 yezigidigidi zeedola.
I-Baotou Traditional Chinese Medicine Co., Ltd.
I-Baotou Traditional Chinese Medicine Co., Ltd., eyasungulwa ngo-1974, yinkampani ye-TCM yanamhlanje edibanisa i-R & D, imveliso, intengiso kunye nenkonzo. Ingeniso yayo malunga ne-10 yezigidi ze-USD.
Kamp Medicine Co., Ltd.
I-Kamp Medicine Co., Ltd., eyasungulwa kwi-1991, ngumenzi wezobisi okhethekileyo uvelisa zombini i-TCM kunye neziyobisi zemichiza eziphatha izifo zenkqubo yokugaya, i-cardiovascular and cerebrovascular disease, izifo zesibindi kunye nezintso, izifo ezichasene ne-microbial, i-tonic kunye nezongezelelo zesondlo, kunye nee-API kunye nezinye iindidi.
I-Guangxi Santo Pharmaceutical Co., Ltd.
I-Guangxi Santo Pharmaceutical Co., Ltd., eyasungulwa ngo-1970, ikhethekileyo kwiyeza laseZhuang. Iimveliso zayo ezikhethekileyo zesizwe "Jiubiying Stomachache Capsule", "Icwecwe leJiubiying Stomachache", "Xiao'er Xieshi Zhixie Powder", kunye neqela lesizwe elikhuselweyo lamayeza emveli aseTshayina, "iTerminalia Throat Tablet", eliyeza lokuqala lokunyanga i-pharyngitis engapheliyo kunye neTonsillitis engapheliyo eTshayina. Iphumelele i "Baihua Award" kunye namanye amabhaso eGuangxi. Ngo-2021, ingeniso yeSanto yayizizigidi ezingama-25.7 zeedola.
I-Hunan Kangshou Pharmaceutical Co., Ltd.
I-Hunan Kangshou Pharmaceutical Co., Ltd., eyasungulwa ngo-2003, ineemvume zeyeza ezingama-52 ezibandakanya iintlobo ezikhethekileyo ze-8 zamayeza emveli aseTshayina, afana ne-Shengxuebao granules, i-Weixiangning granules, i-Maxing Xuanfei granules, i-Yinchen Wuling syrup, i-Guilu Yishen onsul capi Jiangzhuo granules, njl.
Jiangxi Juwang Pharmaceutical Industry Co., Ltd.
I-Jiangxi Juwang Pharmaceutical Industry Co., Ltd., eyasungulwa ngo-1969, ngumvelisi wamachiza okhethekileyo kwiimveliso zesifo senhliziyo, izifo zabasetyhini kunye nezongezo zokutya zokulawula iswekile yegazi. Ngo-2021, ingeniso yeJuwang yayizizigidi ezili-17 zeedola.
IBeijing Tcmages Pharmaceutical Co., Ltd.
I-Beijing Tcmages Pharmaceutical Co., Ltd. ikhethekileyo kuphando kunye nokuveliswa kweegranule zefomula ye-TCM iminyaka engaphezu kwe-20 kunye nesabelo sayo semarike phakathi kwesithathu esiphezulu e-China, kunye neemveliso kunye neenkonzo zayo kwilizwe lonke eziquka izibhedlele ezingaphezu kwe-3,000, kwaye iimveliso zithengiswe kumazwe angaphezu kwama-20 kunye nemimandla kuMntla Melika, iYurophu, i-Ostreliya ye-202cmage, i-202c yezigidi ze-T7, njl. IUSD.
UGuizhou Ruihe Pharmaceutical Co., Ltd.
I-Guizhou Ruihe Pharmaceutical Co., Ltd., eyasungulwa ngo-1998, idibanisa i-R & D, imveliso kunye nokuthengiswa kwe-TCM kunye neziyobisi zemichiza ezigubungela iinaliti ezinomthamo omncinci, iigranules, iipilisi, iipilisi, umgubo, njl.
I-Anhui CR Jinchan Pharmaceutical Co., Ltd. (Yeye-China Resources Sanjiu)
I-Anhui CR Jinchan Pharmaceutical Co., Ltd. yenye yeziseko ezine ezingundoqo zemveliso ye-China Resources Sanjiu Group, ephethe imisebenzi yemveliso yeemveliso ezimbini eziphambili ze-China Resources Sanjiu, ezizezi anti-tumor kunye neegranules zamayeza aseTshayina. Uchungechunge lweCinobufotalin luluhlu lwelizwe laseTshayina olukhuselweyo oluyimfihlo, oluyimveliso yokuqala kunye neyodwa e-China; iigranule zayo zefomula ye-TCM ziphakathi kweemveliso zokuqala zokulinga ezivunyiweyo ngurhulumente, kunye neyokuqala ukuqonda ukwenziwa kwezinto ezikrelekrele eTshayina.
Kangmei Pharmaceutical Co., Ltd.
I-Kangmei Pharmaceutical Co., Ltd., eyasungulwa ngo-1997, ineshishini layo lihamba phezulu, phakathi, ezantsi komsinga kushishino lwamayeza esintu ukusuka ekulinyweni kwemifuno, ukurhweba ukuya kwimveliso kunye nophuhliso kunye neevenkile. Okwangoku, inkampani inamashishini aphantse abe li-100 kulo lonke ilizwe aquka ishishini lokulinywa kwemifuno, imarike yokurhweba ngamayeza, iziko lothutho lwangoku kunye nesiseko semizi-mveliso, yakhe iziseko zemveliso ezili-11 zala maxesha zamaqhekeza kunye namayeza e-TCM, kwaye ilawula ngaphezulu kwe-60% yorhwebo lwelizwe lwentengiso yezityalo. Ngo-2022, ingeniso ye-Kangmei yayiyi-597 yezigidi ze-USD.
I-Hunan Tianjicaotang Pharmaceutical Co., Ltd.
I-Hunan Tianjicaotang Pharmaceutical Co., Ltd. yinkampani edibanisa uphando lwamachiza kunye nophuhliso, ukulinywa kwemifuno, imveliso yamayeza kunye nokuthengisa. Uluhlu oluphambili lweemveliso zenkampani: ukucima ubushushu kunye ne-detoxifying (i-capsule ye-Qingre Sanjie, i-Yanning capsule, i-capsule ye-Chuanwang Xiaoyan, njl.); I-Cardiovascular and cerebrovascular (iipilisi zeNaodesheng, iipilisi ze-breviscapine, njl.); Iimveliso ze-Urinary (i-compound Shilontong capsule, i-compound Shiwei capsule, njl.).
Jiangxi Kingstone Unite Pharmaceutical Co., Ltd.
I-Jiangxi Kingstone Unite Pharmaceutical Co., Ltd., eyasekwa ngo-1978, yinkampani yoxubo-mayeza edibanisa ukulinywa kwemifuno, i-R&D, imveliso kunye nokuthengisa. Iimveliso zisetyenziswa ikakhulu kunyango lwabantwana, kwi-gynecology, kunye nebandayo kunye neyeza lokucoca umkhuhlane.
Isibhedlele saseShuguang Esidityaniswe neYunivesithi yaseShanghai yaseTshayina yezoNyango
ISibhedlele saseShuguang Esidityaniswe neYunivesithi yaseShanghai yaseShayina yezoNyango yiClass-A yeBanga lesi-3 (inqanaba eliphezulu eTshayina) isibhedlele esiqhelekileyo saseTshayina eShanghai. Sesinye sezibhedlele ezili-10 eziphezulu zaseShanghai, kunye nesibhedlele esibonisa amayeza emveli aseTshayina. Isibhedlele sibonelela ngeebhedi ezibhalisiweyo ezili-1,200. Ineempawu ezahlukileyo zeyeza laseTshayina kunye neenzuzo ezibalaseleyo. Inayo i-3 imimandla ephambili yeSebe lezeMfundo: I-Orthopedics kunye ne-Traumatology ye-TCM, i-Medicine yangaphakathi ye-TCM, kunye ne-Chinese Pharmacy (uLungiselelo lwe-Pharmaceutical yaseShayina kunye ne-Clinical Pharmacology ye-TCM), i-9 imimandla ephambili yoLawulo lweSizwe lwe-Traditional Medicine yaseTshayina, i-6 iingcali zeklinikhi eziphambili zeKomishoni yezeMpilo yeSizwe, ii-specialties eziphambili ze-14. ISebe leeNgxamiseko le-TCM liyisiseko esingxamisekileyo soLawulo lweSizwe lweMithi yaseShayina yeNdabuko, iGumbi lokuLungiselela liyisiseko sesizwe sokulungiswa kweyeza zaseTshayina kunye nokuguqulwa kwedosi, kwaye iSebe le-Neurology lisisiseko sokuthintela isifo kunye nokunyangwa kweKomishoni yezeMpilo yeSizwe.
IPhondo laseHunan eliManyaniswe ngokuthe ngqo neSibhedlele seTCM
IPhondo laseHunan eliManyaniswe ngokuthe ngqo neSibhedlele seTCM, esasungulwa ngo-1954, sisibhedlele esiqhelekileyo seBanga lesi-3 leSibhedlele saseTshayina, kunye nesibhedlele esiPhezulu se-100 saseTshayina. Inabasebenzi abangama-2,054, kunye neebhedi ezili-1,800 ezikhoyo. I-acupuncture kunye ne-Moxibustion, i-Hepatology, i-Pulmonary Disease, i-Oncology, kunye ne-Clinical Pharmacy zizinto eziphambili ze-TCM zoLawulo lweSizwe lweMithi yaseTshayina. Ukomelela kwesibhedlele somchamo, utyando lwemithambo-luvo, utyando jikelele, utyando lwebhari, amayeza kaxakeka, ukubelekisa kunye nonyango lwabafazi phakathi kwezona zibalaseleyo kweli phondo.
Isibhedlele sokuqala seYunivesithi yaseHunan yezonyango zaseTshayina
Isibhedlele sokuqala saseHunan University of Chinese Medicine, esekwe ngo-1963, sisiseko sophando lweklinikhi ye-TCM kunye neziko lesizwe lokubonisa imfundiso yezonyango kunye noqeqesho lwe-TCM. Inommandla wokwakha opheleleyo we-610,000 square metres kunye ne-1,800 yeebhedi ezibhalisiweyo. Ifumana ngaphezulu kwe-1.6 yezigidi zezigulane ezingalaliswayo kunye nabaphantse babe ngama-70,000 ngonyaka.
Isibhedlele seSibini seXiangya seYunivesithi yaseCentral South
Isibhedlele seSibini se-Xiangya seYunivesithi yaseCentral South, eyasungulwa kwi-1958, inqanaba le-13 ngamandla abanzi kwizibhedlele zaseTshayina. Inezifundo zeklinikhi eziphambili ezingama-23. Iingcali zayo ezifana ne-Psychiatry, i-endocrinology ye-metabolic, utyando lwe-cardiovascular, i-dermatology kunye nezifo ze-venereal, i-geriatrics, i-nephrology, ikhemesti yeklinikhi, i-organ transplantation, kunye nezinye izinto ezikhethekileyo ziphakathi kweendawo eziphezulu zelizwe. Ike yafumana i-3.948 yezigidi zezigulane ezingaphandle kunye notyelelo olungxamisekileyo, yakhupha izigulane ze-186,000, kwaye yenza imisebenzi ye-146,000 ngonyaka njengeyona meko iphakamileyo. Kwiminyaka yakutshanje, ithathe inxaxheba ekuhlangulweni kwezonyango kwiimeko ezingxamisekileyo zempilo yasekhaya ngamaxesha amaninzi. Ngexesha lothintelo kunye nolawulo lwe-COVID-19, bangaphezulu kwe-600 abantu abathunyelwe eWuhan, Beijing, Xinjiang, West Africa nakwezinye iindawo ukulwa lo bhubhani, babekwe phakathi kwabaphezulu eTshayina.
Isibhedlele seSibini seYunivesithi yaseHunan yezonyango zaseTshayina (iSibhedlele saseTshayina saseHunan)
Yasekwa ngo-1934, iSibhedlele seSibini saseHunan University of Chinese Medicine, ekwaziwa ngokuba yiHunan Chinese Medicine Hospital, sisibhedlele esingundoqo sephondo seBanga lesi-3 samayeza aseTshayina. Ngoku inabasebenzi abangaphezu kwe-1,200, iibhedi ze-1,156 ezikhoyo, amasebe angama-51 ezonyango kunye nobuchwepheshe bezonyango; Iingcali ezi-4 eziphambili zesizwe: I-Proctology, i-Dermatology, i-Orthopedics, i-Gynecology; Iinkalo ze-3 eziphambili zoLawulo lweSizwe lweMithi yaseTshayina yeMveli: i-TCM dermatology, i-TCM Proctology, ukuvuselelwa kwe-TCM; Iingcali ezi-9 eziphambili zoLawulo lweSizwe lweMithi yaseTshayina yeMveli: I-Proctology, i-Dermatology, i-Orthopaedics, i-Gynecology, i-Encephalopathy, i-cardiovascular medicine, i-spleen kunye nezifo zesisu, i-Otolaryngology, i-Prevention and Health care of TCM.
I-Orthopedics ye-Traditional Chinese Medicine eZhuzhou City
I-Orthopedics of Traditional Chinese Medicine iSixeko saseZhuzhou, esasungulwa ngo-1958, kunye "ne-Shi's" yokumisela amathambo emveli kunye nobuchwepheshe bonyango lweyeza njengelifa lemfundo, i-Class-A yeBanga-3 isibhedlele esikhethekileyo sokulimala kwamathambo. Ibeke iNombolo ye-62 phakathi kwesibhedlele esiPhezulu se-TCM se-TCM kwiinzuzo zeempawu ze-TCM kunye nefuthe lobuchwepheshe kwi-2020.